Artesunet 50 mg Tablet

Artesunet 50 mg Tablet is a medication used to treat malaria. The intravenous form is preferred to quinine for severe malaria. Often it is used as part of combination therapy, such as artesunate plus mefloquine.

Intravenous Artesunet 50 mg Tablet was safe and effective in treating severe malaria in adults in the United States, researchers reported in Clinical Infectious Diseases.

Common side effects of Artesunet 50 mg Tablet are include:

• Hives.
• Rash.
• Hemoglobinuria.
• Seizures.
• Neuropsychiatric reactions.
• Reversible neurologic changes.

Artesunet 50 mg Tablet and other antimalarials also appear to be effective and safe in the first trimester of pregnancy, when development of malaria carries a high risk of miscarriage.

Limited information indicates that a maternal dose of 200 mg orally produced low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months.

Artesunet 50 mg Tablet and alcohol together has not been proven to cause harm, therefore it is safe to drink while taking your malaria tablets. However, as always, it is best to consume alcohol within the recommended guidelines to stay safe and look after your health.

Artesunet 50 mg Tablet causes drowsiness and dizziness it is advisable to you do not drive unless you are alert.

It should be taken between 8 and 12 hours after the last injection of Artesunet 50 mg Tablet. Until the patient is able to take oral medication.

The recommended dosage of Artesunet 50 mg Tablet for Injection is 2.4 mg/kg administered intravenously at 0 hours, 12 hours, and 24 hours, and thereafter, administered once daily until the patient is able to tolerate oral antimalarial therapy.

Artesunet 50 mg Tablet are active against the different asexual forms of the Plasmodium parasites and clear parasitemia within 48 to 72 hours.

The elimination half-life of Artesunet 50 mg Tablet is about 0.22 hours.

The adult dose is 1 tablet weekly. Child dosage is also once a week, but the amount will depend on their weight. It should be started 3 weeks before you travel and taken all the time you're in a risk area, and for 4 weeks after you get back.

Continue Artesunet 50 mg Tablet treatment one dose a day for a maximum of 7 days.

You should not use Artesunet 50 mg Tablet if you are allergic to it. Tell your doctor if you have ever had kidney problems. Tell your doctor if you are pregnant. Malaria is more likely to cause serious illness or death in a pregnant woman.

The overdose was associated with pancytopenia, melena, seizures, multiorgan failure and death. Treatment of overdose should consist of general supportive measures.

In a medical setting you are not likely to miss a dose.

The present study suggests that Artesunet 50 mg Tablet could cause duration-dependent hemolysis and hypoglycemia probably via free radical generation, inactivation of antioxidant enzymes, and stimulation of insulin secretion.

Study showed that intravenous Artesunet 50 mg Tablet does not have significant cardiovascular effects.

These findings suggest that Artesunet 50 mg Tablet decreases glomerular filtration rate and increases renal blood flow and urinary excretion of Na, Cl, and K.

Artesunet 50 mg Tablet administration of high doses of Artesunet 50 mg Tablet by the oral route produced considerable damage to the liver.

Artesunet 50 mg Tablet did not cause any significant effects in short-term administration but significantly reduced the aforesaid parameters in long-term administration. There were visible lesions in the testicular and epididymal histological studies, although fertility was not significantly reduced.